arstechnica.com
·
Aug 19
mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
The vaccine reportedly thwarted the cancer's return and spread.
Discussion
0 comments
Want to join the discussion?
Log in
or
create an account.
No comments yet. Start the discussion.